<!DOCTYPE html>
<html>
  <head>
    <title>Cervical Screening</title>
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <meta charset="utf-8">
    <!-- Bootstrap -->
    <link href="//netdna.bootstrapcdn.com/bootswatch/3.2.0/flatly/bootstrap.min.css" rel="stylesheet" media="screen">
    <link href="/css/site.css" rel="stylesheet" media="screen">
    <link href="/css/syntax.css" rel="stylesheet" media="screen">

    <!-- HTML5 Shim and Respond.js IE8 support of HTML5 elements and media queries -->
    <!-- WARNING: Respond.js doesn't work if you view the page via file:// -->
    <!--[if lt IE 9]>
      <script src="https://oss.maxcdn.com/libs/html5shiv/3.7.0/html5shiv.js"></script>
      <script src="https://oss.maxcdn.com/libs/respond.js/1.3.0/respond.min.js"></script>
    <![endif]-->
<script>
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','//www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-48968311-4', 'jandecaluwe.com');
  ga('send', 'pageview');

</script>
  </head>

  <body>

    <!-- Fixed navbar -->
    <div class="navbar navbar-default navbar-fixed-top">
      <div class="container">
        <div class="navbar-header">
          <button type="button" class="navbar-toggle" data-toggle="collapse" data-target=".navbar-collapse">
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
            <span class="icon-bar"></span>
          </button>
          <a class="navbar-brand" href="/">Rory’s notes</a>
        </div>
        <div class="navbar-collapse collapse">

          <ul class="nav navbar-nav navbar-left">
 
          </ul>

          <ul class="nav navbar-nav navbar-right">
            <li class="active"><a href="/notes/">notes</a></li>
          </ul>

        </div><!--/.nav-collapse -->
      </div>
    </div>


<div class="container">

  <ol class="breadcrumb">
    <li><a href="/">Home</a></li>
      <li><a href="/notes/">notes</a></li>
      <li><a href="/notes/womens_health/">womens_health</a></li>
      <li class="active">Cervical Screening</li>
  </ol>

  <div class="page-header">
 
    <h1>Cervical Screening</h1>
  </div>

  <div class="row">

    <div class="col-md-3" role="navigation"> 
 
      <div class="sidebar" data-spy="affix" data-offset-top="80" data-offset-bottom="60">
        <div class="well">
          <a href="#"><strong>Cervical Screening</strong></a>
          <div class="toc">
<ul>
<li><a href="#liquid-based-cytology">Liquid based cytology</a></li>
<li><a href="#when-to-screen-how-often">when to screen + how often</a></li>
<li><a href="#normal-smear">Normal Smear:</a></li>
<li><a href="#unsatisfactory-smear">Unsatisfactory smear:</a></li>
<li><a href="#women-with-abnormal-smears">women with abnormal smears</a><ul>
<li><a href="#low-grade-squamous-abnormalities-asc-us-lsil">Low-grade squamous abnormalities: ASC-US + LSIL</a><ul>
<li><a href="#guidance-asc-uslsil">Guidance: asc-us/lsil</a></li>
<li><a href="#histologically-confirmed-lsil">Histologically confirmed LSIL</a></li>
</ul>
</li>
<li><a href="#high-grade-squamous-abnormalites">High-grade squamous abnormalites</a><ul>
<li><a href="#recommendation">Recommendation</a></li>
</ul>
</li>
<li><a href="#management-of-previous-cin2-or-3">Management of previous CIN2 or 3</a></li>
</ul>
</li>
<li><a href="#cervical-glandular-abnormalities">cervical glandular abnormalities</a></li>
<li><a href="#pregnancy">Pregnancy</a></li>
<li><a href="#post-meno-pausal-women-and-women-6240-with-noraml-endometrial-cells">post meno-pausal women and women >40 with noraml endometrial cells</a></li>
<li><a href="#immunocompromised-women">immunocompromised women</a></li>
<li><a href="#previous-hysterectomy">previous hysterectomy</a><ul>
<li><a href="#sub-total-hysterectomy-cervix-remains-for-benign-regions">Sub-total hysterectomy (cervix remains) for benign regions</a></li>
<li><a href="#total-hysterectomy">Total hysterectomy</a></li>
</ul>
</li>
<li><a href="#hpv-testing">HPV testing</a><ul>
<li><a href="#asc-us-or-lsil-6230yo">ASC-US or LSIL >30yo:</a></li>
<li><a href="#high-grade-lesion">High grade lesion</a></li>
<li><a href="#post-colposcopy-with-discordant-results">Post colposcopy with discordant results</a></li>
</ul>
</li>
</ul>
</div>

        </div>
      </div>
    </div>
 
    <div class="content">
      <div class="col-md-6" role="main">
        <p><a href="http://www.nsu.govt.nz/files/NCSP/Guidelines_for_Cervical_Screening_in_New_Zealand.pdf">National screening unit NZ guidelines</a></p>
<ul>
<li>
<p>long latency - taking average 10-20yrs to develop</p>
</li>
<li>
<p>HPV 16&amp;18 cause up to 70% cervical cancer</p>
<ul>
<li>Garasil</li>
</ul>
</li>
<li>
<p>in NZ 160 women diagnosed with cervical cancer</p>
<ul>
<li>60 die</li>
</ul>
</li>
</ul>
<blockquote>
<p>HrHPV = high risk hpv</p>
<p>16,18,31,33,39</p>
</blockquote>
<h3 id="liquid-based-cytology">Liquid based cytology</h3>
<ul>
<li>
<p>=SurePath and ThinPrep</p>
</li>
<li>
<p>do not use wooden spatula</p>
</li>
<li>
<p>reduction in rate of unsatisfactory smears, shorter time for interpretation</p>
</li>
<li>
<p>ability to use same sample for HPV</p>
</li>
<li>
<p>use water based lubricant - sparingly trying to avoid tip of speculum( can use warm water)</p>
</li>
<li>
<p>transferred into vial cf. glass slide</p>
</li>
<li>
<p>ideal sample = squamous cells which line the ectocervix and small number of endocervical glandular cells = indicates squamocolumnar junction sampled</p>
</li>
<li>
<p>if looks abnormal or abnormal symptoms then colposcopy</p>
</li>
<li>
<p>indications for cytobrush:</p>
<ul>
<li>
<p>repeat smears on patients with abnormal</p>
</li>
<li>
<p>anatmoy of canal has been altered</p>
</li>
<li>
<p>repeating smear where previously no endocervical cells were obtained</p>
</li>
<li>
<p>abnormal bleeding</p>
</li>
</ul>
</li>
<li>
<p>to avoid bleeding only rotate 1/4 - 1/2 turn</p>
</li>
</ul>
<h3 id="when-to-screen-how-often">when to screen + how often</h3>
<ul>
<li>
<p>recommended fora ll women who are or who have ever been sexually active</p>
</li>
<li>
<p>3 yearly from 20yo - 69yo</p>
</li>
<li>
<p>first smear or more than 5 years b/w smears:</p>
<ul>
<li>second smear recommended one year after first then 3 yearly</li>
</ul>
</li>
<li>
<p>>69yo good quality smears difficult to obtain</p>
</li>
</ul>
<blockquote>
<ul>
<li>65 low risk of developing cervical cancer</li>
</ul>
</blockquote>
<h3 id="normal-smear">Normal Smear:</h3>
<ul>
<li>
<p>if negative: recall 3 years unless:</p>
<ul>
<li>if first smear: follow-up 1 year (or 5yrs b/w smears)</li>
</ul>
</li>
</ul>
<h3 id="unsatisfactory-smear">Unsatisfactory smear:</h3>
<ul>
<li>
<p>inadequate for some reason</p>
</li>
<li>
<p>three main types:</p>
<ul>
<li>
<p>taking smear; inadequate sampling of cells, contact bleeding, poor fixation, unwanted artefacts</p>
</li>
<li>
<p>clinical factors: bleeding, inflmamtion, cyolysis</p>
</li>
<li>
<p>laboratory technical factors</p>
</li>
</ul>
</li>
<li>
<p>reported as a non-result</p>
</li>
<li>
<p>3 unsatisfactory: recommend colposcopy to exclude high-grade lesion</p>
</li>
<li>
<p>use liquid based cytology technique for collection and transport following unsatisfactory</p>
</li>
<li>
<p>recommendation:</p>
<ul>
<li>
<p>repeat within 3 months</p>
</li>
<li>
<p>refer colposcopy after 3 consecutive </p>
</li>
</ul>
</li>
</ul>
<h3 id="women-with-abnormal-smears">women with abnormal smears</h3>
<h4 id="low-grade-squamous-abnormalities-asc-us-lsil">Low-grade squamous abnormalities: ASC-US + LSIL</h4>
<ul>
<li>
<p>cervical cancer very rare outcome of a low-grade abnormality</p>
<ul>
<li>
<p>if cancer diagnosed:</p>
<ul>
<li>
<p>under-calling on index cytology</p>
</li>
<li>
<p>true progession</p>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>risk CIN2/3 similar with LSIL and atypical squamous cells of undertmined significance (ASC-US).</p>
<ul>
<li>
<p>both show similar high regression rates</p>
</li>
<li>
<p>managed similarily</p>
</li>
</ul>
</li>
<li>
<p>manifestation of viral infection</p>
</li>
<li>
<p>resolve spont \&lt;30yo majority</p>
</li>
<li>
<p>recall 12/12 aged 20-29 as median time for clearance = 6-18mo</p>
</li>
<li>
<p>>30yo HrHPV increase risk of developing high-grade lesion</p>
<ul>
<li>
<p>infection more likely to be persistant</p>
</li>
<li>
<p>HPV triage hreater benefit than repeated cytology to asses underlying risk of HSIL</p>
</li>
</ul>
</li>
<li>
<p>symptoms/appearacne of cervix abnormal refer colposcopy</p>
</li>
<li>
<p>low grade = low risk</p>
</li>
</ul>
<h5 id="guidance-asc-uslsil">Guidance: asc-us/lsil</h5>
<ul>
<li>
<p>20-69 with abnormal smear within last 5:</p>
<ul>
<li>refer <strong>colposcopy</strong></li>
</ul>
</li>
<li>
<p>20-29 no abnormal smear within last 5 yrs:</p>
<ul>
<li>repeat <strong>smear 12 months</strong></li>
</ul>
</li>
<li>
<p>>30yo with no abnormal smear</p>
<ul>
<li>
<p>offered HPV test</p>
<ul>
<li>
<p>if reflex HrHPV -ve:</p>
<ul>
<li>
<p>repeat <strong>12 months</strong></p>
<ul>
<li>
<p>if negative:</p>
<ul>
<li>return <strong>normal screening</strong></li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>if positive:</p>
<ul>
<li>refer <strong>colposcopy</strong></li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>if 12 month repeat:</p>
<ul>
<li>
<p>HSIL/ASC-H:</p>
<ul>
<li><strong>colposcopy</strong></li>
</ul>
</li>
<li>
<p>ASC-US/LSIL</p>
<ul>
<li><strong>colposcopy</strong></li>
</ul>
</li>
<li>
<p>negative</p>
<ul>
<li>smear <strong>12 months</strong></li>
</ul>
</li>
</ul>
</li>
<li>
<p>if colposcopy:</p>
<ul>
<li>
<p>satisfactory and normal:</p>
<ul>
<li>
<p>2x annual smears:</p>
<ul>
<li>
<p>if both <strong>negative</strong></p>
<ul>
<li><strong>resume routine screening</strong></li>
</ul>
</li>
<li>
<p>if either <strong>abnormal</strong>:</p>
<ul>
<li><strong>colposcopy</strong></li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>Satisfactory and abnormal</p>
<ul>
<li>target biopsy</li>
</ul>
</li>
<li>
<p>Unsatisfactory</p>
<ul>
<li>
<p>cytology</p>
<ul>
<li>
<p>if low grade:</p>
<ul>
<li>repeat colpsocopy and cytology 12 months</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
<h5 id="histologically-confirmed-lsil">Histologically confirmed LSIL</h5>
<ul>
<li>
<p>treatment not recommended</p>
</li>
<li>
<p>smears 12 &amp; 24 months</p>
</li>
<li>
<p>if both -ve</p>
<ul>
<li>return to routine</li>
</ul>
</li>
<li>
<p>if either positive;</p>
<ul>
<li>refer back to colposcopy</li>
</ul>
</li>
</ul>
<h4 id="high-grade-squamous-abnormalites">High-grade squamous abnormalites</h4>
<ul>
<li>
<p>CIN2/CIN3</p>
<ul>
<li>
<p>moderate dysplasia</p>
</li>
<li>
<p>severe dysplasia/carcinoma in situ</p>
</li>
</ul>
</li>
<li>
<p>women with untreated CIN3 are at high risk of cervical cancer</p>
</li>
<li>
<p>cin2 more heterogenous </p>
</li>
<li>
<p>CIN2 = threshold for treatment</p>
<ul>
<li>
<p>except \&lt;20yo </p>
<ul>
<li>lieklyhood of regression = high</li>
</ul>
</li>
<li>
<p>and pregnancy</p>
</li>
</ul>
</li>
</ul>
<h5 id="recommendation">Recommendation</h5>
<ul>
<li>
<p>ASC-H or HSILL</p>
<ul>
<li>refer <strong>colonoscopy</strong> and biopsy</li>
</ul>
</li>
<li>
<p>if biopsy:</p>
<ul>
<li>
<p>satis and abnormal</p>
<ul>
<li>biopsy</li>
</ul>
</li>
<li>
<p>satis and normal or negative biopsy</p>
<ul>
<li>
<p>cytology review</p>
</li>
<li>
<p>if review confirms high-grade</p>
<ul>
<li>
<p><strong>repeat colpsocopy and cytology in 3/12</strong></p>
<ul>
<li>
<p>if N</p>
<ul>
<li>repeat 12 months</li>
</ul>
</li>
<li>
<p>if LSIL</p>
<ul>
<li>review MDT</li>
</ul>
</li>
<li>
<p>if HSIL</p>
<ul>
<li>treatment</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>unsatisfactory</p>
<ul>
<li>
<p>cytology recommemended</p>
<ul>
<li>
<p>if HSIL</p>
<ul>
<li>knife cone biopsy</li>
</ul>
</li>
<li>
<p>ASC-US or LSIL</p>
<ul>
<li>MDT</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
</ul>
</li>
<li>
<p>LLETZ </p>
<ul>
<li>
<p>failure rate = 10%</p>
</li>
<li>
<p>risk of further high-graade disease and invasive cancer increases with age</p>
</li>
</ul>
</li>
</ul>
<h4 id="management-of-previous-cin2-or-3">Management of previous CIN2 or 3</h4>
<ul>
<li>
<p>HrHPV = high sensitivity for detecting persistent CIN2/3 post treatment</p>
<ul>
<li>allows for shortening of surveillance period</li>
</ul>
</li>
<li>
<p>Routine f/u:</p>
<ul>
<li>
<p>treated for CIN 2 or 3 should have colposcopy and smear 6-12mo</p>
</li>
<li>
<p>any symptoms managed</p>
</li>
<li>
<p>cervical smear 12mo after then annually until 70</p>
</li>
<li>
<p>HrHPV can be used to identify women at risk of persistent or rcurrent lesions</p>
</li>
</ul>
</li>
</ul>
<h3 id="cervical-glandular-abnormalities">cervical glandular abnormalities</h3>
<ul>
<li>
<p>represent 15-20% invasive cervical cancer</p>
</li>
<li>
<p>less effective at preventing cervical adenocarcinoma cf. squamous</p>
<ul>
<li>limitation of cervical smear test</li>
</ul>
</li>
<li>
<p>HrHPV: cervical adenocarcinoma and AIS (in-situ) in \~90%</p>
</li>
<li>
<p>not uncommon for atypical glandular cells (AGC) associated with underlying neoplastic condition</p>
</li>
<li>
<p>all glandular abnormalaties referred to gynae</p>
</li>
<li></li>
</ul>
<h3 id="pregnancy">Pregnancy</h3>
<ul>
<li>
<p>no CI taking smears</p>
</li>
<li>
<p>routine delayed until after pregnancy</p>
<ul>
<li>unless overdue</li>
</ul>
</li>
<li>
<p>risk of progression of CIN2/3 to invasive cancer during pregnancy is low</p>
</li>
<li>
<p>high probability that high grade lesion will persist</p>
</li>
<li>
<p>continued colposcopic and cytlogical during pregnancy (20-30/40) and post partum</p>
</li>
</ul>
<h3 id="post-meno-pausal-women-and-women-6240-with-noraml-endometrial-cells">post meno-pausal women and women >40 with noraml endometrial cells</h3>
<ul>
<li>
<p>benign endometrial cells in post-menopausal women may be associated with significant endometiral pathology</p>
<ul>
<li>further assessment required</li>
</ul>
</li>
<li>
<p>normal cells;</p>
<ul>
<li>correllate with uterine symptoms</li>
</ul>
</li>
<li>
<p>atypical endometrial cells</p>
<ul>
<li>
<p>high correlation</p>
</li>
<li>
<p>urgent referral for colposcopy</p>
</li>
</ul>
</li>
</ul>
<h3 id="immunocompromised-women">immunocompromised women</h3>
<ul>
<li>
<p>annual screening</p>
</li>
<li>
<p>abnormal - any grade</p>
<ul>
<li>colposcopy</li>
</ul>
</li>
</ul>
<h3 id="previous-hysterectomy">previous hysterectomy</h3>
<h4 id="sub-total-hysterectomy-cervix-remains-for-benign-regions">Sub-total hysterectomy (cervix remains) for benign regions</h4>
<ul>
<li>routine screening</li>
</ul>
<h4 id="total-hysterectomy">Total hysterectomy</h4>
<ul>
<li>
<p>normal cytology/histology 5yrs preceeding hysterectomy do <strong>not</strong> require vaginal vault cytology</p>
</li>
<li>
<p>unkown - baseline vaginal vault cytology</p>
<ul>
<li>if Normal then no further</li>
</ul>
</li>
<li>
<p>previous CIN1</p>
<ul>
<li>3 yearly vaginal vault cytology until age 70yo</li>
</ul>
</li>
<li>
<p>CIN2/3</p>
<ul>
<li>
<p>guidelines for high grade</p>
<ul>
<li>annual vaginal vault until age 70yo</li>
</ul>
</li>
<li>
<p>genital malignancy</p>
<ul>
<li>oncologist surveillance</li>
</ul>
</li>
</ul>
</li>
</ul>
<h3 id="hpv-testing">HPV testing</h3>
<ul>
<li>
<p>majority of high-risk HPV infections clear within 2 years</p>
<ul>
<li>are of little clinical significance</li>
</ul>
</li>
<li>
<p>high NPV (\~99%)</p>
</li>
<li>
<p>more sensitive for detecting risk of High grade lesions than conventioanl cytology - more specific test</p>
</li>
</ul>
<h4 id="asc-us-or-lsil-6230yo">ASC-US or LSIL >30yo:</h4>
<ul>
<li>
<p>-ve ‘reflex’ test: very unlikely to have signifiant lesion</p>
<ul>
<li>
<p>repeat cytology 12/12</p>
<ul>
<li>if negative -> normal 3 yearly</li>
</ul>
</li>
</ul>
</li>
<li>
<p>+’ve -> colposcopy</p>
</li>
</ul>
<h4 id="high-grade-lesion">High grade lesion</h4>
<ul>
<li>
<p>increase risk of further high gradde disease and cervical cancer</p>
</li>
<li>
<p>better id women @ risk</p>
</li>
<li>
<p>HrHPV+cytology @ 12 months after treatment and annually until women negative both tests x 2 12/12 apart</p>
<ul>
<li>then 3 yearly interval</li>
</ul>
</li>
</ul>
<h4 id="post-colposcopy-with-discordant-results">Post colposcopy with discordant results</h4>
<ul>
<li>
<p>single colpsocopic exam can miss signifiant lesions</p>
</li>
<li>
<p>HrHPV - cytology Pos</p>
<ul>
<li>if ASC-H</li>
</ul>
</li>
</ul>
      </div>
    </div>

  </div>
    

    <div class="footer">
        <p>Website powered by <a href="http://urubu.jandecaluwe.com">Urubu</a></p>
    </div>


</div> 


    <!-- jQuery (necessary for Bootstrap's JavaScript plugins) -->
    <script src="https://code.jquery.com/jquery.js"></script>
    <!-- Include all compiled plugins (below), or include individual files as needed -->
    <script src="//netdna.bootstrapcdn.com/bootstrap/3.2.0/js/bootstrap.min.js"></script>

  </body>
</html>
